Detalhe da pesquisa
1.
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
N Engl J Med
; 383(17): 1624-1634, 2020 10 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33085861
2.
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial.
Br J Dermatol
; 189(5): 511-519, 2023 10 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37290787
3.
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
J Allergy Clin Immunol
; 149(5): 1683-1690.e7, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34954198
4.
Lirentelimab for severe and chronic forms of allergic conjunctivitis.
J Allergy Clin Immunol
; 150(3): 631-639, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35390403
5.
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab.
Clin Gastroenterol Hepatol
; 20(3): 535-545.e15, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34089846
6.
Sodium zirconium cyclosilicate in hyperkalemia.
N Engl J Med
; 372(3): 222-31, 2015 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25415807
7.
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.
Kidney Int
; 88(2): 404-11, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25651363
8.
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.
JAMA
; 312(21): 2223-33, 2014 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-25402495
9.
New agents for hyperkalemia.
N Engl J Med
; 372(16): 1571-2, 2015 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-25884064
10.
Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
JCI Insight
; 4(19)2019 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31465299
11.
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
Int J Cardiol
; 216: 46-51, 2016 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27140336
12.
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Circulation
; 108(16): 1933-8, 2003 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-14504183
13.
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
Clin Cancer Res
; 10(17): 5747-53, 2004 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15355902
14.
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
Eur J Heart Fail
; 17(10): 1050-6, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26011677
15.
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions.
Hum Gene Ther
; 13(1): 15-63, 2002 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11779412
16.
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.
Hum Gene Ther
; 13(1): 65-100, 2002 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11779413
17.
Characterization of structure and function of ZS-9, a K+ selective ion trap.
PLoS One
; 9(12): e114686, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25531770
18.
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
Catheter Cardiovasc Interv
; 68(3): 372-8, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16892433
19.
Looking into anti-angiogenic gene therapies for disorders of the eye.
Drug Discov Today
; 6(22): 1171-1175, 2001 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-11700219
20.
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
Lancet Oncol
; 3(11): 665-71, 2002 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-12424068